A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP
BackgroundEvidence suggests that organizational models that provide care interventions including patient support programs may increase patient adherence to multiple sclerosis (MS) therapies by providing tailored symptom management, informational support, psychological and/or social support, lifestyl...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Psychology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyg.2022.965229/full |
| _version_ | 1798036150036725760 |
|---|---|
| author | Serena Barello Damiano Paolicelli Roberto Bergamaschi Salvatore Cottone Alessandra D'Amico Viviana Annibali Andrea Paolillo Caterina Bosio Valentina Panetta Guendalina Graffigna |
| author_facet | Serena Barello Damiano Paolicelli Roberto Bergamaschi Salvatore Cottone Alessandra D'Amico Viviana Annibali Andrea Paolillo Caterina Bosio Valentina Panetta Guendalina Graffigna |
| author_sort | Serena Barello |
| collection | DOAJ |
| description | BackgroundEvidence suggests that organizational models that provide care interventions including patient support programs may increase patient adherence to multiple sclerosis (MS) therapies by providing tailored symptom management, informational support, psychological and/or social support, lifestyle changes, emotional adjustment, health education, and tailored coaching, thus improving patients' overall quality of life across the disease course.ObjectiveThe main objective of this study was to describe MS patients' self-reported experience of a nurse-led, telephone-based PSP and to explore its potential role in improving disease and therapy management skills.MethodsSurvey data were analyzed from a subset of patients relapsing–remitting MS (RRMS) using interferon beta-1a already registered in the adveva® PSP from three Italian multiple sclerosis centers with a consolidated experience in RRMS disease, treatment management, and PSP programs.ResultsIn total, 244 patient data at baseline were analyzed, of which 115 had a follow-up of at least 6 months. Results from this study provide an early view into the role of this PSP in improving the patients reported overall experience regarding disease management and injectable therapy, thus potentially ameliorating treatment adherence and decreasing health care cost. Moreover, study findings confirm the role of providing a patient-focused support by addressing non-medication-related topics in the PSP consultations. Indeed, patients involved in the adveva® PSP program reported a better psychological status in the follow up as demonstrated by an increased optimism regarding their future, tolerance of disease uncertainty, and their perceived ability to benefit from external help and social support (informal caregivers).ConclusionsAs such, it is reasonable to conclude that the involvement in the adveva® PSP and the PSP's assistance in guiding patients on proper treatment self-management techniques is of great value to patients as it might contribute to improving engagement in their health care journey in terms of perceived self-care skills, emotional coping toward the future and the unpredictability of the disease course and their general attitudes toward the injection itself, involving pain tolerance. |
| first_indexed | 2024-04-11T21:08:32Z |
| format | Article |
| id | doaj.art-0fc0a5836cdf4969a0aa5d781dbda1a2 |
| institution | Directory Open Access Journal |
| issn | 1664-1078 |
| language | English |
| last_indexed | 2024-04-11T21:08:32Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychology |
| spelling | doaj.art-0fc0a5836cdf4969a0aa5d781dbda1a22022-12-22T04:03:08ZengFrontiers Media S.A.Frontiers in Psychology1664-10782022-08-011310.3389/fpsyg.2022.965229965229A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSPSerena Barello0Damiano Paolicelli1Roberto Bergamaschi2Salvatore Cottone3Alessandra D'Amico4Viviana Annibali5Andrea Paolillo6Caterina Bosio7Valentina Panetta8Guendalina Graffigna9EngageMinds HUB, Department of Psychology, Consumer, Food & Health Engagement Research Center, Università Cattolica del Sacro Cuore, Milan, ItalyDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari “Aldo Moro”, Bari, ItalyIRCCS Mondino Foundation, Pavia, ItalyUOC Neurologia con Stroke Unit ARNAS Civico, Palermo, ItalyMedical Affairs Department, Merck Serono S.p.A., Rome, Italy, An Affiliate of Merck KGaA, Darmstadt, GermanyMedical Affairs Department, Merck Serono S.p.A., Rome, Italy, An Affiliate of Merck KGaA, Darmstadt, GermanyMedical Affairs Department, Merck Serono S.p.A., Rome, Italy, An Affiliate of Merck KGaA, Darmstadt, GermanyEngageMinds HUB, Department of Psychology, Consumer, Food & Health Engagement Research Center, Università Cattolica del Sacro Cuore, Cremona, ItalyL'altrastatisticasrl, Consultancy & Training, Biostatistics Office, Rome, ItalyEngageMinds HUB, Department of Psychology, Consumer, Food & Health Engagement Research Center, Università Cattolica del Sacro Cuore, Cremona, ItalyBackgroundEvidence suggests that organizational models that provide care interventions including patient support programs may increase patient adherence to multiple sclerosis (MS) therapies by providing tailored symptom management, informational support, psychological and/or social support, lifestyle changes, emotional adjustment, health education, and tailored coaching, thus improving patients' overall quality of life across the disease course.ObjectiveThe main objective of this study was to describe MS patients' self-reported experience of a nurse-led, telephone-based PSP and to explore its potential role in improving disease and therapy management skills.MethodsSurvey data were analyzed from a subset of patients relapsing–remitting MS (RRMS) using interferon beta-1a already registered in the adveva® PSP from three Italian multiple sclerosis centers with a consolidated experience in RRMS disease, treatment management, and PSP programs.ResultsIn total, 244 patient data at baseline were analyzed, of which 115 had a follow-up of at least 6 months. Results from this study provide an early view into the role of this PSP in improving the patients reported overall experience regarding disease management and injectable therapy, thus potentially ameliorating treatment adherence and decreasing health care cost. Moreover, study findings confirm the role of providing a patient-focused support by addressing non-medication-related topics in the PSP consultations. Indeed, patients involved in the adveva® PSP program reported a better psychological status in the follow up as demonstrated by an increased optimism regarding their future, tolerance of disease uncertainty, and their perceived ability to benefit from external help and social support (informal caregivers).ConclusionsAs such, it is reasonable to conclude that the involvement in the adveva® PSP and the PSP's assistance in guiding patients on proper treatment self-management techniques is of great value to patients as it might contribute to improving engagement in their health care journey in terms of perceived self-care skills, emotional coping toward the future and the unpredictability of the disease course and their general attitudes toward the injection itself, involving pain tolerance.https://www.frontiersin.org/articles/10.3389/fpsyg.2022.965229/fullpatient support programmultiple sclerosistreatment adherencepatient engagementdisease modifying therapiespatient reported outcomes |
| spellingShingle | Serena Barello Damiano Paolicelli Roberto Bergamaschi Salvatore Cottone Alessandra D'Amico Viviana Annibali Andrea Paolillo Caterina Bosio Valentina Panetta Guendalina Graffigna A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP Frontiers in Psychology patient support program multiple sclerosis treatment adherence patient engagement disease modifying therapies patient reported outcomes |
| title | A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP |
| title_full | A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP |
| title_fullStr | A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP |
| title_full_unstemmed | A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP |
| title_short | A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP |
| title_sort | nurse led telephone based patient support program for improving adherence in patients with relapsing remitting multiple sclerosis using interferon beta 1a lessons from a consumer based survey on adveva r psp |
| topic | patient support program multiple sclerosis treatment adherence patient engagement disease modifying therapies patient reported outcomes |
| url | https://www.frontiersin.org/articles/10.3389/fpsyg.2022.965229/full |
| work_keys_str_mv | AT serenabarello anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT damianopaolicelli anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT robertobergamaschi anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT salvatorecottone anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT alessandradamico anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT vivianaannibali anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT andreapaolillo anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT caterinabosio anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT valentinapanetta anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT guendalinagraffigna anurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT serenabarello nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT damianopaolicelli nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT robertobergamaschi nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT salvatorecottone nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT alessandradamico nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT vivianaannibali nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT andreapaolillo nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT caterinabosio nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT valentinapanetta nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp AT guendalinagraffigna nurseledtelephonebasedpatientsupportprogramforimprovingadherenceinpatientswithrelapsingremittingmultiplesclerosisusinginterferonbeta1alessonsfromaconsumerbasedsurveyonadvevapsp |